✓ Bengaluru
✓ ZCCK Registered
✓ ZCCK Registered
Portal hypertension is the common endpoint of advanced liver disease — causing variceal bleeding, ascites, and encephalopathy. Each complication is a potential emergency. Early specialist management prevents crises and extends life. Expert hepatology at Dhaara Liver Clinic, Yelahanka.
The portal vein carries blood from the intestines, stomach, and spleen to the liver for processing. Normal portal venous pressure is 5–10 mmHg. When the liver is scarred (cirrhosis), blood cannot flow freely through it — pressure backs up, elevating portal pressure above 12 mmHg.
This elevated pressure forces blood to find alternative routes to the heart — through collateral veins (varices) in the oesophagus, stomach, rectum, and abdominal wall. These thin-walled varices are prone to rupture, causing life-threatening bleeding.
| Cause | India Prevalence |
|---|---|
| Cirrhosis (HBV, HCV, alcohol, MASLD) | Most common — 70% |
| Non-cirrhotic portal fibrosis (NCPF) | Higher in India than Western countries |
| Extrahepatic portal vein obstruction (EHPVO) | Common in children & young adults |
| Budd-Chiari syndrome | Hepatic vein obstruction — higher incidence in India |
| Schistosomiasis | Limited to endemic areas |
| Nodular regenerative hyperplasia | Rare; drug-induced or autoimmune |
Rupture of oesophageal or gastric varices. Presents as haematemesis (vomiting blood) or melaena. Each episode carries 15–30% mortality. Requires immediate endoscopy, vasoactive drugs, antibiotics.
Fluid accumulation in the abdomen. Causes abdominal distension, discomfort, and shortness of breath. Managed with salt restriction, diuretics (spironolactone + furosemide), and therapeutic paracentesis when tense.
Bacterial infection of ascitic fluid — occurs in 8–10% of hospitalised cirrhotics. Presents with fever, abdominal pain, worsening encephalopathy. Requires IV antibiotics and ascitic fluid analysis. SBP after a variceal bleed is a specific high-risk scenario.
Confusion, altered consciousness, and asterixis (flapping tremor) from ammonia accumulation. Precipitated by infection, GI bleeding, constipation, dehydration, or sedatives. Treated with lactulose and rifaximin.
Enlarged spleen causing low platelets, anaemia, and leukopenia. Significantly elevated INR and low platelet count can complicate invasive procedures and surgery.
Acute kidney injury in cirrhosis from extreme portal hypertension and vasoconstriction. Type 1 HRS (AKI) is life-threatening — MELD escalates rapidly. Requires terlipressin, albumin infusion, and urgent transplant evaluation.
All cirrhotic patients should have diagnostic upper GI endoscopy at diagnosis to screen for varices. If medium/large varices are present: non-selective beta-blockers (propranolol or carvedilol — preferred) or endoscopic variceal band ligation (EVL). Either reduces bleeding risk by 40–50%. This is the most important preventive intervention in cirrhosis.
Immediate terlipressin IV (or octreotide) to reduce portal pressure. Prophylactic antibiotics (ceftriaxone 1g IV) — reduces bacterial infection and mortality. Urgent upper endoscopy within 12 hours for EVL or cyanoacrylate injection (for gastric varices). Avoid over-transfusion — Hb target 7–8 g/dL.
Combination of non-selective beta-blockers + EVL reduces re-bleeding risk from 65% (untreated) to 25–30%. Repeat EVL sessions every 2–4 weeks until varices are obliterated. Beta-blockers are lifelong. Compliance is critical — re-bleeding on treatment is the major cause of preventable deaths.
For acute variceal haemorrhage uncontrolled by endoscopy and pharmacotherapy: TIPS within 72 hours reduces mortality significantly. Early TIPS (within 72h in Child C / MELD 10–18) patients also benefits high-risk patients before re-bleeding. Requires interventional radiology expertise.
When ascites requires large-volume paracentesis more than 3 times per month despite maximum diuretics, TIPS creates a portosystemic shunt that eliminates the pressure gradient driving ascitic fluid formation. Contraindicated in severe hepatic encephalopathy, MELD above 18, right heart failure.
All portal hypertension complications from cirrhosis are best treated by liver transplant — the only intervention that eliminates the underlying cause. MELD score, Child-Pugh class, and decompensation events (ascites, variceal bleed, SBP, HRS, encephalopathy) determine transplant urgency. Dr. Srinivas evaluates all decompensated patients for transplant listing.
Also called hepatoportal sclerosis or idiopathic portal hypertension. Affects predominantly young adults in India — possibly linked to recurrent intestinal infections and arsenic exposure. Features: splenomegaly, variceal bleeding, but well-preserved liver function (unlike cirrhosis). Biopsy shows obliterative portal venopathy. Good prognosis — patients can survive decades with variceal management. Does not require transplant in most cases.
Portal vein thrombosis from birth or early infancy — often following umbilical catheterisation or neonatal infection. Presents in children or young adults with splenomegaly, hypersplenism (low platelets), and variceal bleeding. Liver function is usually completely normal. Treatment includes EVL for varices, anticoagulation in select cases, and the Rex shunt (mesenterico-left portal bypass) in children to restore physiological portal flow.
Obstruction of hepatic veins or inferior vena cava causing congestive liver damage and sinusoidal hypertension. India has a high incidence, often related to hypercoagulable states, polycythaemia vera, or membranous IVC obstruction (different from Western HBV-linked Budd-Chiari). Presents acutely (fulminant) or insidiously. Treatment: anticoagulation, TIPS, angioplasty for IVC stenosis, and liver transplant for fulminant or chronic cases with liver failure.
Portal hypertension is elevated pressure in the portal vein system that drains blood from the gut and spleen to the liver. Normal portal pressure is 5–10 mmHg. When it rises above 12 mmHg, complications begin. In India, the most common cause is cirrhosis — from chronic hepatitis B, hepatitis C, alcohol, or fatty liver disease. India also has a significant burden of non-cirrhotic portal hypertension — conditions like non-cirrhotic portal fibrosis (NCPF) and extrahepatic portal vein obstruction (EHPVO) that cause portal hypertension with preserved liver function. Correct diagnosis is critical because treatment and prognosis differ completely.
Vomiting blood (haematemesis) or passing black, tarry, sticky stools (melaena) in anyone with known liver disease, cirrhosis, or portal hypertension is a variceal haemorrhage until proven otherwise. This is a life-threatening emergency. Go to A&E immediately — do not try to manage this at home. In hospital, treatment includes: terlipressin injection (reduces portal pressure), IV antibiotics (reduces infection risk which worsens outcomes), blood transfusion targeting Hb 7–8 g/dL, and urgent endoscopy within 12 hours for variceal band ligation. Without immediate expert treatment, mortality from each episode is 15–30%.
TIPS (Transjugular Intrahepatic Portosystemic Shunt) is an interventional radiology procedure that creates a channel through the liver, connecting the portal vein directly to the hepatic vein, bypassing the liver's resistance. This dramatically lowers portal pressure. TIPS is used when standard treatments have failed: refractory ascites needing frequent paracentesis; variceal bleeding not controlled by endoscopy and beta-blockers; acute bleeding uncontrolled at endoscopy (salvage TIPS). TIPS significantly increases risk of hepatic encephalopathy because blood bypasses the liver's filtering. It is not suitable for patients with poor liver function (high bilirubin, MELD above 18) or right heart failure.
An enlarged spleen (splenomegaly) in the context of liver disease or abnormal liver blood tests is a classic feature of portal hypertension. High pressure in the portal system causes blood to pool in the spleen, enlarging it. The enlarged spleen then destroys blood cells at an accelerated rate (hypersplenism), causing: low platelets (thrombocytopenia — bruising, bleeding risk), anaemia, and sometimes low white cell count. If your ultrasound shows splenomegaly alongside liver abnormalities, you need a full portal hypertension assessment including upper GI endoscopy to look for varices. Do not ignore this finding.
Portal hypertension from cirrhosis cannot be reversed because the underlying cirrhosis is irreversible — the scar tissue in the liver is permanent. However, complications can be managed effectively: varices can be banded and suppressed with beta-blockers; ascites can be controlled with salt restriction and diuretics; encephalopathy can be prevented with lactulose and rifaximin. The only definitive cure for cirrhotic portal hypertension is liver transplant — replacing the scarred liver with a healthy one normalises portal pressure completely and eliminates all complications. For non-cirrhotic causes (NCPF, EHPVO), treating the underlying condition or creating surgical shunts can be more definitive.
Yes — absolutely. Compensated cirrhosis means the liver is scarred but still functioning adequately without overt complications. However, portal hypertension is often already present at this stage, with varices forming silently. Every patient with compensated cirrhosis should have: upper GI endoscopy to screen for varices; Fibroscan or liver stiffness measurement; 6-monthly HCC surveillance. If medium or large varices are found, prophylactic beta-blockers or band ligation prevents bleeding. The transition from compensated to decompensated cirrhosis (first variceal bleed, first ascites, first encephalopathy episode) carries a 5-year mortality of 40–50% — prevention is far better than treatment.